Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

07. April 2026 22:01 ET | Quelle: Kahn Swick & Foti, LLC

Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Soleno (SLNO) Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit
07. April 2026 21:57 ET | Quelle: Kahn Swick & Foti, LLC

Navan, Inc. Notice of April 24, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Navan (NAVN) Investors Have Opportunity to Lead Navan, Inc. Securities Lawsuit
07. April 2026 21:57 ET | Quelle: Kahn Swick & Foti, LLC

Trip.com Group Limited Securities Fraud Class Action Result of Antitrust Probe and 19% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

NEW YORK and NEW ORLEANS, April 07, 2026 (GLOBE NEWSWIRE) -- What’s Happening: Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr.,...
07. April 2026 21:57 ET | Quelle: Kahn Swick & Foti, LLC

Super Micro Computer, Inc. Notice of May 26, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Super Micro (SMCI) Investors Have Opportunity to Lead Super Micro Computer, Inc. Securities Fraud Lawsuit
07. April 2026 21:50 ET | Quelle: Kahn Swick & Foti, LLC

ImmunityBio, Inc. Securities Fraud Class Action Result of FDA Warning and 21% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

ImmunityBio (IBRX) Investors Have Opportunity to Lead ImmunityBio, Inc Securities Fraud Lawsuit
07. April 2026 21:47 ET | Quelle: Kahn Swick & Foti, LLC

uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

uniQure (QURE) Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit
07. April 2026 21:44 ET | Quelle: Kahn Swick & Foti, LLC

Gemini Space Station, Inc. Notice of May 18, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Gemini (GEMI) Investors Have Opportunity to Lead Gemini Space Station, Inc. Securities Fraud Lawsuit
07. April 2026 21:35 ET | Quelle: Kahn Swick & Foti, LLC

Enphase Energy, Inc. Notice of April 20, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Enphase (ENPH) Investors Have Opportunity to Lead Enphase Energy, Inc. Securities Fraud Lawsuit
07. April 2026 21:35 ET | Quelle: Kahn Swick & Foti, LLC

Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Corcept (CORT) Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit
07. April 2026 21:33 ET | Quelle: Kahn Swick & Foti, LLC

Kyndryl Holdings, Inc. Notice of April 13, 2026 Application Deadline for Class Action Lawsuits - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Kyndryl (KD) Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit

Nächste Seite